{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:17Z","timestamp":1787010017792,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To describe the patterns of ocular inflammation after coronavirus disease 2019 vaccination, assess underlying commonalities, and understand outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Retrospective, multicenter cohort study, conducted between 2020 and 2021. Patients with no previous uveitis history (\n                      <jats:italic toggle=\"yes\">de novo<\/jats:italic>\n                      ) or a known uveitis history (recurrent) who developed ocular inflammation within 42 days of coronavirus disease 2019 vaccination were identified. Characteristics of the uveitis, treatment approaches, and clinical outcomes were assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fifty-five eyes of 39 patients with ocular inflammation temporally related to vaccination were identified. Twenty-two patients (36 eyes) were\n                      <jats:italic toggle=\"yes\">de novo<\/jats:italic>\n                      , while 17 (19 eyes) were recurrent. Anterior uveitis was most common. HLA-B27 positivity was found in 6 (27.2%)\n                      <jats:italic toggle=\"yes\">de novo<\/jats:italic>\n                      patients, and 5 (29.4%) recurrent patients. Most patients required only observation, topical, or systemic corticosteroids. Among vaccinated patients, 12.3% of new uveitis referrals during the study period were related to coronavirus disease 2019 vaccination. Among patients with a history of quiescent uveitis, only 0.85% experienced a flare after vaccination.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Most inflammation thought to be secondary to coronavirus disease 2019 vaccination achieved quiescence with observation or steroids, and the overall incidence is low. Anterior uveitis was the most common. HLA-B27 positivity occurred at a higher rate than reported in the baseline population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004413","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:00:57Z","timestamp":1737561657000},"page":"1175-1183","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["THE HETEROGENEOUS PRESENTATIONS OF DE NOVO AND RECURRENT OCULAR INFLAMMATION AFTER COVID-19 VACCINATION"],"prefix":"10.1097","volume":"45","author":[{"given":"Sruthi","family":"Arepalli","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Emory University, Atlanta, Georgia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kopplin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Wisconsin, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Tsui","sequence":"additional","affiliation":[{"name":"Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brill","sequence":"additional","affiliation":[{"name":"Chesapeake Retina Centers, Gambrills, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Sobrin","sequence":"additional","affiliation":[{"name":"Massachusetts Eye and Ear Infirmary, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Papaliodis","sequence":"additional","affiliation":[{"name":"Massachusetts Eye and Ear Infirmary, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Darwish","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Cook County Hospital, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Raiji","sequence":"additional","affiliation":[{"name":"Illinois Retina Associates, Chicago, Illinois;"},{"name":"Department of Ophthalmology, Rush University Medical Center, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Janardhana","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Massachusetts, Worcester, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Emami-Naeini","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of California, Davis, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lish","family":"Nore","sequence":"additional","affiliation":[{"name":"Tennessee Retina, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Parker","sequence":"additional","affiliation":[{"name":"Tennessee Retina, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Tennessee Retina, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"945930","DOI":"10.3389\/fimmu.2022.945930","article-title":"A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"109061","DOI":"10.1016\/j.intimp.2022.109061","article-title":"Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination","volume":"110","author":"Safary","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ophtha.2022.08.027","article-title":"Vaccine-associated uveitis after COVID-19 vaccination: vaccine adverse event reporting system database analysis","volume":"130","author":"Singh","year":"2023","journal-title":"Ophthalmology"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12348-021-00275-x","article-title":"Ocular inflammatory events following COVID-19 vaccination: a multinational case series","volume":"12","author":"Testi","year":"2022","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.3390\/jcm10245960","article-title":"Uveitis and other ocular complications following COVID-19 vaccination","volume":"10","author":"Bolletta","year":"2021","journal-title":"J Clin Med"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10384-022-00962-9","article-title":"A multicenter study of ocular inflammation after COVID-19 vaccination","volume":"67","author":"Yasaka","year":"2023","journal-title":"Jpn J Ophthalmol"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4103\/2211-5056.353129","article-title":"Ocular inflammatory manifestations following COVID-19 vaccinations in Taiwan: a case series","volume":"12","author":"Wang","year":"2022","journal-title":"Taiwan J Ophthalmol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/IAE.0000000000003277","article-title":"Uveitis after the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association","volume":"41","author":"Rabinovitch","year":"2021","journal-title":"Retina"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00417-022-05798-0","article-title":"New onset of acute uveitis following COVID-19 vaccination","volume":"261","author":"Sim","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/09273948.2022.2058964","article-title":"COVID-19 vaccination and uveitis: epidemiology, clinical features and visual prognosis","volume":"30","author":"Ferrand","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1080\/21645515.2019.1708669","article-title":"Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination","volume":"16","author":"Nandi","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/cid\/ciz135","article-title":"Principal controversies in vaccine safety in the United States","volume":"69","author":"DeStefano","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.survophthal.2021.04.001","article-title":"Ocular adverse events following vaccination: overview and update","volume":"67","author":"Cheng","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/09273948.2019.1626188","article-title":"Vaccine-associated uveitis","volume":"27","author":"Cunningham","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ophtha.2023.07.017","article-title":"Risk of noninfectious uveitis after coronavirus disease 2019 vaccination in a United States claims database","volume":"130","author":"Kumar","year":"2023","journal-title":"Ophthalmology"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/annrheumdis-2021-221490","article-title":"Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry","volume":"81","author":"Machado","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"919979","DOI":"10.3389\/fimmu.2022.919979","article-title":"The flare of rheumatic disease after SARS-CoV-2 vaccination: a review","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/art.33503","article-title":"The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009","volume":"64","author":"Reveille","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/09273948.2016.1175642","article-title":"Review for disease of the year: epidemiology of HLA-B27 associated ocular disorders","volume":"24","author":"Kopplin","year":"2016","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T10:47:53Z","timestamp":1748342873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004413"}},"subtitle":["A Multicenter Report and a Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004413","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}